Med Student Medical News about Papillomavirus Vaccines Uterine Cervical Neoplasms Vaccination Mass Screening

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in the United States
Annals of Internal Medicine, 10/20/09

Kim JJ et al. – This analysis assessed the cost–effectiveness of HPV vaccination for women aged 35 to 45 years. It found that vaccination ranged from $116 950 to $381 590 per quality–adjusted life–year gained across various assumptions about how clinicians would screen for cervical cancer and HPV infection in addition to vaccination. Given currently available information, the effectiveness of HPV vaccination for women older than 30 years who are screened seems to be small. Compared with current screening that uses sensitive HPV DNA testing, HPV vaccination is associated with less attractive cost–effectiveness ratios in this population than those for other, well–accepted interventions in the United States.

<< Previous
Personal characteristics and experiences of long-term allied...

Next >>
Systematic Review: Comparative Effectiveness of...

A cost-utility analysis of cervical cancer vaccination in preadolescent Canadian females
BMC Public Health, 11/17/09 Relevance Score: 96%

State-Level Differences in Breast and Cervical Cancer Screening by Disability Status: United States, 2008
Women's Health Issues, 11/04/09 Relevance Score: 93%

Effectiveness of cervical cancer screening at different ages
Women's Health, 10/30/09 Relevance Score: 93%

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09 Relevance Score: 90%

Human papillomavirus vaccination in survivors of childhood cancer
Cancer, 10/12/09 Relevance Score: 90%